Wilson Marc
Insider CIK 1702265 · CDTX Chief Accounting Officer · CRNX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-09-26 | 2024-09-30 | 25,000 | — | $0 | 89,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-09-26 | 2024-09-30 | 25,000 | $15.29 | $382.3K | 136,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-09-26 | 2024-09-30 | 25,000 | $51.11 | $1.28M | 111,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-25 | 2024-07-26 | 19,056 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-25 | 2024-07-26 | 19,056 | $53.88 | $1.03M | 111,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-25 | 2024-07-26 | 19,056 | $9.28 | $176.8K | 130,148 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-15 | 2024-07-17 | 25,000 | — | $0 | 66,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-15 | 2024-07-17 | 25,000 | $55.00 | $1.38M | 111,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-15 | 2024-07-17 | 25,000 | $20.02 | $500.5K | 136,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-06-28 | 2024-07-02 | 32,129 | — | $0 | 19,056 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-06-28 | 2024-07-02 | 32,129 | $9.28 | $298.2K | 143,221 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-28 | 2024-07-02 | 32,129 | $43.61 | $1.40M | 111,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-19 | 2024-03-20 | 6,942 | $42.91 | $297.9K | 110,630 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 3,983 | $38.14 | $151.9K | 117,572 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 95,500 | — | $0 | 95,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 25,500 | — | $0 | 121,555 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-01-02 | 2024-01-04 | 10,000 | — | $0 | 51,185 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-01-02 | 2024-01-04 | 10,000 | $9.28 | $92.8K | 106,055 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-01-02 | 2024-01-04 | 10,000 | $35.47 | $354.7K | 96,055 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-11-01 | 2023-11-03 | 10,000 | — | $0 | 61,185 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-11-01 | 2023-11-03 | 10,000 | $28.75 | $287.5K | 95,601 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-11-01 | 2023-11-03 | 10,000 | $9.28 | $92.8K | 105,601 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-06-20 | 2023-06-21 | 20,000 | — | $0 | 71,185 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-06-20 | 2023-06-21 | 10,922 | $19.96 | $218.0K | 95,158 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-06-20 | 2023-06-21 | 20,000 | $9.28 | $185.6K | 115,158 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-06-20 | 2023-06-21 | 20,000 | $19.97 | $399.4K | 95,158 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2023-03-16 | 2023-03-17 | 1,666 | $17.12 | $28.5K | 106,080 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 112,850 | — | $0 | 112,850 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 24,200 | — | $0 | 107,746 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-02-28 | 2022-03-02 | 91,000 | — | $0 | 91,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2022-02-28 | 2022-03-02 | 19,500 | — | $0 | 81,618 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-02-26 | 2021-03-02 | 114,000 | — | $0 | 114,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-02-24 | 2020-02-26 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2019-03-08 | 2019-03-12 | 56,250 | — | $0 | 56,250 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2017-09-18 | 2017-09-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2017-09-18 | 2017-09-19 | 5,000 | — | $0 | 10,356 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-03-31 | 2017-04-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-03-16 | 2017-04-04 | 12,000 | — | $0 | 12,000 | SEC↗ |